# Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

> **NCT01129284** · PHASE4 · COMPLETED · sponsor: **Columbia University** · enrollment: 15 (actual)

## Conditions studied

- Treatment Resistant Nephrotic Syndrome

## Interventions

- **DRUG:** ACTHAR gel

## Key facts

- **NCT ID:** NCT01129284
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129284, "Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01129284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*